Page 6 – The Progeria Research Foundation

Thank you for making a difference in 2018!

Feb 28, 2019 | Events

At PRF, every donation is valued. PRF’s success would not have been possible without each and every one of our donors! Your support made 2018 a tremendous year of progress. In 2018… We learned that lonafarnib gives children with Progeria longer lives. We...

October 2018: PRF Redesigns the Research Grant Program and is Soliciting Grant Proposals Worldwide

Oct 18, 2018 | News

Our 2018 Newsletter is Here!

Sep 11, 2018 | News

FANTASTIC NEWS! Study Published in JAMA Finds Treatment Extends Survival In a spectacular development, a new study published in The Journal of the American Medical Association (JAMA) shows that treatment with lonafarnib extends lifespan in children with Progeria. This...

On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib

May 16, 2018 | News

Collaboration marks the first submission for the treatment of Progeria. If approved, children may access drug by prescription instead of clinical trial!! Read our latest press releases here: Progeria Research Foundation Announces Collaboration and Supply Agreement...

Night of Wonder 2018: Music to your ears!

Apr 28, 2018 | Events, News

Night of Wonder 2018: Music to your ears! Saturday Evening, April 28, 2018Renaissance Waterfront in Boston, MA PRF’s phenomenal 2018 Night of Wonder, signature gala & auction, was a huge success! We truly did Rock the Cure! TOGETHER we raised just over...

April 24, 2018: Global Study Published in JAMA Finds Treatment with Lonafarnib Extends Survival in Children with Progeria!

Apr 24, 2018 | News

A new study published in The Journal of the American Medical Association (JAMA) brings new hope and optimism to the Progeria community. Get the news here: Global Study Published in JAMA Finds Treatment with Lonafarnib Extends Survival in Children with...